Please enable JavaScript to continue using this application.

Compare $DSGN vs $SLDB | Chartloom

Compare

$DSGN vs $SLDB

Design Therapeutics Inc · Solid Biosciences Inc

DSGN

Design Therapeutics Inc

SLDB

Solid Biosciences Inc

Compare $DSGN vs $SLDB

Comparing Design Therapeutics Inc and Solid Biosciences Inc

DSGNDesign Therapeutics Inc

SLDBSolid Biosciences Inc

DSGNDesign Therapeutics Inc

Market cap

$728M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

28.0%

52W performance

67.9%

FCF yield

-7.6%

SLDBSolid Biosciences Inc

Market cap

$676M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

26.1%

52W performance

8.9%

FCF yield

-27.8%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

DSGN

SLDB

Detailed metrics comparison

DSGN

Design Therapeutics Inc

SLDB

Solid Biosciences Inc

Market Cap

DSGN$728M

SLDB$676M

Enterprise Value

DSGN$715M

SLDB$517M

Price

DSGN$11.65

SLDB$6.87

P/E Ratio

DSGNN/A

SLDBN/A

P/S Ratio

DSGN0.00x

SLDB49.66x

EV/Sales

DSGN0.00x

SLDB38.88x

EV/EBITDA

DSGN0.00x

SLDB0.00x

P/B Ratio

DSGN3.83x

SLDB1.96x

P/FCF Ratio

DSGNN/A

SLDBN/A

EV/FCF

DSGN-12.96x

SLDB-2.75x

PEG Ratio

DSGNN/A

SLDBN/A

Forward P/E (NTM)

DSGNN/A

SLDBN/A

Forward P/S (NTM)

DSGNN/A

SLDBN/A

Revenue (TTM)

DSGN$0

SLDB$0

Revenue Growth (YoY)

DSGNN/A

SLDBN/A

Forward Rev Growth

DSGN1360.4%

SLDB822.7%

Gross Margin (TTM)

DSGN0.0%

SLDB0.0%

Operating Margin (TTM)

DSGN0.0%

SLDB0.0%

EBITDA Margin (TTM)

DSGN0.0%

SLDB0.0%

Net Margin (TTM)

DSGN0.0%

SLDB0.0%

FCF Margin (TTM)

DSGNN/A

SLDBN/A

Net Income (TTM)

DSGN$-71M

SLDB$-207M

FCF (TTM)

DSGN$-55M

SLDB$-188M

EPS (TTM)

DSGN-$1.13

SLDB-$1.44

ROE (TTM)

DSGN-3403.0%

SLDB-7228.0%

ROA (TTM)

DSGN-3205.0%

SLDB-6137.0%

ROIC (TTM)

DSGN-3403.0%

SLDB-7226.0%

Cash

DSGN$13M

SLDB$159M

Debt

DSGN$0

SLDB$0

Net Cash/Debt

DSGN$13M

SLDB$159M

Current Ratio (TTM)

DSGN18.86x

SLDB13.82x

Quick Ratio (TTM)

DSGN18.61x

SLDB13.24x

Debt/Equity (TTM)

DSGN0.00x

SLDB0.00x

Debt/Assets (TTM)

DSGN0.0%

SLDB0.0%

Interest Coverage (TTM)

DSGNN/A

SLDBN/A

Net Debt/EBITDA (TTM)

DSGN0.00x

SLDB0.00x

Beta

DSGN1.72

SLDB2.60

52W Performance

DSGN67.9%

SLDB8.9%

YTD Performance

DSGN28.0%

SLDB26.1%

% from 52W High

DSGN-32.5%

SLDB-40.0%

% from 52W Low

DSGN120.6%

SLDB81.3%

Asset Turnover (TTM)

DSGN0.00x

SLDB0.07x

FCF Yield (TTM)

DSGN-7.6%

SLDB-27.8%

Earnings Yield (TTM)

DSGN-9.7%

SLDB-30.6%

Dividend Yield (TTM)

DSGNN/A

SLDBN/A

Rule of 40

DSGN0.0

SLDB0.0

EV/GP/RG

DSGNN/A

SLDBN/A

Ticker research

View DSGN research View SLDB research

Metric	DSGN Design Therapeutics Inc	SLDB Solid Biosciences Inc
Market & Valuation
Market Cap	$728M	$676M
Enterprise Value	$715M	$517M
Price	$11.65	$6.87
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	49.66x
EV/Sales	0.00x	38.88x
EV/EBITDA	0.00x	0.00x
P/B Ratio	3.83x	1.96x
P/FCF Ratio	N/A	N/A
EV/FCF	-12.96x	-2.75x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	1360.4%	822.7%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-71M	$-207M
FCF (TTM)	$-55M	$-188M
EPS (TTM)	-$1.13	-$1.44
ROE (TTM)	-3403.0%	-7228.0%
ROA (TTM)	-3205.0%	-6137.0%
ROIC (TTM)	-3403.0%	-7226.0%
Financial Health
Cash	$13M	$159M
Debt	$0	$0
Net Cash/Debt	$13M	$159M
Current Ratio (TTM)	18.86x	13.82x
Quick Ratio (TTM)	18.61x	13.24x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.72	2.60
52W Performance	67.9%	8.9%
YTD Performance	28.0%	26.1%
% from 52W High	-32.5%	-40.0%
% from 52W Low	120.6%	81.3%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.07x
FCF Yield (TTM)	-7.6%	-27.8%
Earnings Yield (TTM)	-9.7%	-30.6%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View DSGN research	View SLDB research

Valuation

P/S Ratio

DSGN

0.00x

SLDB

49.66x

EV/FCF

DSGN

-12.96x

SLDB

-2.75x

Growth & revenue

Forward Revenue Growth

DSGN

1360.4%

SLDB

822.7%

Profitability & performance

Gross Margin

DSGN

0.0%

SLDB

0.0%

ROE

DSGN

-3403.0%

SLDB

-7228.0%

FCF Yield %

DSGN

-7.6%

SLDB

-27.8%

52-Week Performance

DSGN

67.9%

SLDB

8.9%

Detailed metrics comparison

DSGN

Design Therapeutics Inc

SLDB

Solid Biosciences Inc

Market Cap

DSGN$728M

SLDB$676M

Enterprise Value

DSGN$715M

SLDB$517M

Price

DSGN$11.65

SLDB$6.87

P/E Ratio

DSGNN/A

SLDBN/A

P/S Ratio

DSGN0.00x

SLDB49.66x

EV/Sales

DSGN0.00x

SLDB38.88x

EV/EBITDA

DSGN0.00x

SLDB0.00x

P/B Ratio

DSGN3.83x

SLDB1.96x

P/FCF Ratio

DSGNN/A

SLDBN/A

EV/FCF

DSGN-12.96x

SLDB-2.75x

PEG Ratio

DSGNN/A

SLDBN/A

Forward P/E (NTM)

DSGNN/A

SLDBN/A

Forward P/S (NTM)

DSGNN/A

SLDBN/A

Revenue (TTM)

DSGN$0

SLDB$0

Revenue Growth (YoY)

DSGNN/A

SLDBN/A

Forward Rev Growth

DSGN1360.4%

SLDB822.7%

Gross Margin (TTM)

DSGN0.0%

SLDB0.0%

Operating Margin (TTM)

DSGN0.0%

SLDB0.0%

EBITDA Margin (TTM)

DSGN0.0%

SLDB0.0%

Net Margin (TTM)

DSGN0.0%

SLDB0.0%

FCF Margin (TTM)

DSGNN/A

SLDBN/A

Net Income (TTM)

DSGN$-71M

SLDB$-207M

FCF (TTM)

DSGN$-55M

SLDB$-188M

EPS (TTM)

DSGN-$1.13

SLDB-$1.44

ROE (TTM)

DSGN-3403.0%

SLDB-7228.0%

ROA (TTM)

DSGN-3205.0%

SLDB-6137.0%

ROIC (TTM)

DSGN-3403.0%

SLDB-7226.0%

Cash

DSGN$13M

SLDB$159M

Debt

DSGN$0

SLDB$0

Net Cash/Debt

DSGN$13M

SLDB$159M

Current Ratio (TTM)

DSGN18.86x

SLDB13.82x

Quick Ratio (TTM)

DSGN18.61x

SLDB13.24x

Debt/Equity (TTM)

DSGN0.00x

SLDB0.00x

Debt/Assets (TTM)

DSGN0.0%

SLDB0.0%

Interest Coverage (TTM)

DSGNN/A

SLDBN/A

Net Debt/EBITDA (TTM)

DSGN0.00x

SLDB0.00x

Beta

DSGN1.72

SLDB2.60

52W Performance

DSGN67.9%

SLDB8.9%

YTD Performance

DSGN28.0%

SLDB26.1%

% from 52W High

DSGN-32.5%

SLDB-40.0%

% from 52W Low

DSGN120.6%

SLDB81.3%

Asset Turnover (TTM)

DSGN0.00x

SLDB0.07x

FCF Yield (TTM)

DSGN-7.6%

SLDB-27.8%

Earnings Yield (TTM)

DSGN-9.7%

SLDB-30.6%

Dividend Yield (TTM)

DSGNN/A

SLDBN/A

Rule of 40

DSGN0.0

SLDB0.0

EV/GP/RG

DSGNN/A

SLDBN/A

Ticker research

View DSGN research View SLDB research

Metric	DSGN Design Therapeutics Inc	SLDB Solid Biosciences Inc
Market & Valuation
Market Cap	$728M	$676M
Enterprise Value	$715M	$517M
Price	$11.65	$6.87
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	49.66x
EV/Sales	0.00x	38.88x
EV/EBITDA	0.00x	0.00x
P/B Ratio	3.83x	1.96x
P/FCF Ratio	N/A	N/A
EV/FCF	-12.96x	-2.75x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	1360.4%	822.7%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-71M	$-207M
FCF (TTM)	$-55M	$-188M
EPS (TTM)	-$1.13	-$1.44
ROE (TTM)	-3403.0%	-7228.0%
ROA (TTM)	-3205.0%	-6137.0%
ROIC (TTM)	-3403.0%	-7226.0%
Financial Health
Cash	$13M	$159M
Debt	$0	$0
Net Cash/Debt	$13M	$159M
Current Ratio (TTM)	18.86x	13.82x
Quick Ratio (TTM)	18.61x	13.24x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.72	2.60
52W Performance	67.9%	8.9%
YTD Performance	28.0%	26.1%
% from 52W High	-32.5%	-40.0%
% from 52W Low	120.6%	81.3%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.07x
FCF Yield (TTM)	-7.6%	-27.8%
Earnings Yield (TTM)	-9.7%	-30.6%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View DSGN research	View SLDB research